Charterhouse Acquires Labomar S.p.A.
September 7, 2023
Charterhouse Capital Partners has invested in Labomar S.p.A., partnering with founder and CEO Walter Bertin and existing minority shareholder Cleon Capital; Labomar's shares were delisted as part of the transaction. Charterhouse will support Labomar's next phase of growth via a buy-and-build strategy to consolidate fragmented markets and expand the company's CDMO capabilities across food supplements, medical devices and functional cosmetics.
- Buyers
- Charterhouse Capital Partners LLP, LBM Next (tender offer vehicle)
- Targets
- Labomar S.p.A.
- Industry
- Pharmaceuticals
- Location
- Italy
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.